Health Sciences

Secondary cancers following CAR T cell therapy are rare

A new Penn Medicine analysis shows that the development of any type of second cancer is a rare occurrence, and some of the earliest patients have gone on to experience long-lasting remissions of a decade or more.

From Penn Medicine News

Breaching the blood-brain barrier

A team of researchers in the School of Engineering and Applied Sciences has devised a method to deliver mRNA into the brain using lipid nanoparticles, potentially advancing treatments for Alzheimer’s disease and seizures.

Nathi Magubane



In the News


Philadelphia Inquirer

Inside Penn’s transfer center

Penn Medicine’s transfer command center gets patients from affiliated hospitals and hospitals outside Philadelphia to specialized care that can save lives, with comments from CEO Kevin Mahoney.

FULL STORY →



The Wall Street Journal

The quest for treatments to keep weight off after Ozempic

Researchers at Penn are conducting a co-authored study of the brains, fat and muscle cells, and eating patterns of people trying to maintain new body sizes.

FULL STORY →



Philadelphia Inquirer

Operating rooms are major sources of greenhouse gasses. Penn is eliminating a form of anesthesia that hangs in the air for more than a decade after use

Penn Medicine is phasing out the anesthesia desflurane at four of its six hospitals to eliminate harmful greenhouse gases, with remarks from Greg Evans.

FULL STORY →



Fox 29 (Philadelphia)

Cannabis reclassification could be game-changer for U.S. drug policy

Michael Cirigliano of the Perelman School of Medicine says that marijuana deserves to be removed from the same category as LSD, heroin, and fentanyl.

FULL STORY →



Philadelphia Inquirer

These two Philly-area nurses are on a mission to get nursing recognized as a STEM field

Marion Leary of the School of Nursing is co-leading a national coalition seeking to convince federal agencies to recognize the field of nursing as a STEM profession.

FULL STORY →